Mapping morphological malformation to genetic dysfunction in blood vessel organoids with 22q11.2 Deletion Syndrome

Siyu He, Cong Xu, Yeh‐Hsing Lao, Shradha Chauhan, Yang Xiao, Moshe J. Willner, Yinuo Jin, Shannon McElroy, Sneha Rao, Joseph A. Gogos, Raju Tomer, Elham Azizi, Bin Xu, Kam W. LeongbioRxiv 2021 · DOI

Abstract

22q11.2 Deletion Syndrome (22q11.2 DS), also known as DiGeorge Syndrome, is a genetic disorder characterized by microdeletions on chromosome 22, resulting in significant vascular deficits such as abnormal aortic arch morphology and tortuous retinal vessels. Despite its clinical prevalence, the precise mechanisms by which dysfunctional endothelial and mural cells contribute to these vasculopathies remain poorly understood. This study utilizes human blood vessel organoids (VOs) derived from patient iPSCs to model these malformations. By integrating high-resolution lightsheet imaging, deep learning-mediated segmentation, and single-cell transcriptomics, we identify a breakdown in cellular communication and structural stability. Our findings reveal that 22q11.2 DS VOs exhibit increased but unstable sprouting, reduced connectivity, and a shift from direct cell-cell contact to upregulated extracellular matrix (ECM) signaling, providing a new framework for understanding and potentially treating 22q11.2 DS vasculopathy.

Introduction

The human vascular system is a complex 3D architecture that is difficult to replicate in traditional 2D cultures or animal models. In 22q11.2 Deletion Syndrome, the resulting vascular malformations—including tetralogy of Fallot and irregular vessel branching—suggest a fundamental defect in the developmental process of endothelial cells (ECs) and supporting mural cells (pericytes and smooth muscle cells). To bridge the gap between genetic deletion and physical phenotype, this research employs 3D blood vessel organoids (VOs) to provide a high-fidelity window into human-specific genetic dysfunction.

Methodology

The study utilized a multi-modal analytical pipeline to evaluate 84 organoids generated from three pairs of 22q11.2 DS patient iPSC lines and healthy controls.

Tissue Engineering and Imaging

VOs were engineered to contain both ECs and mural cells. To quantify the complex 3D structures, the researchers employed DeepVesselNet, a fully convolutional neural network, for automated vascular segmentation, and CellPose for nuclei identification. This removed the subjectivity of manual analysis and allowed for high-throughput characterization of the vascular networks.

Topological and Spatial Analysis

The vascular networks were modeled as mathematical graphs. Connectivity, tortuosity, and degree distribution were calculated to assess network robustness. Furthermore, Voronoi diagram-based tessellation was used to quantify the spatial co-localization of endothelial tubes and mural cells at the pixel level, providing a metric for structural integrity.

Single-Cell Transcriptomics

Single-cell RNA sequencing (scRNA-seq) was performed on 13,797 individual cells. The data were analyzed using Scanpy for clustering and CellChat to infer intercellular communication patterns, specifically looking at how the genetic deletion altered the signaling pathways between ECs and mural cells.

Key Findings

The Paradox of Sprouting and Network Instability

A primary morphological discovery was that 22q11.2 DS organoids exhibited significantly smaller volumes and lower mean vascular radii (approximately 6.83 µm compared to 8.02 µm in controls). Interestingly, the diseased organoids showed increased vascular density and sprouting. However, graph theory analysis revealed this was an unproductive expansion; the networks had lower connectivity and a higher "degree exponent," suggesting a system that is more vulnerable to perturbations and lacks the structural robustness of healthy vasculature.

The "Broken Conversation": Cellular Communication Deficits

Transcriptomic profiling identified significant heterogeneity and organ-specific alterations in endothelial characteristics. The most striking finding was a drastic reduction in direct cell-cell contact signaling. In control VOs, 296 contact-based interactions were identified, whereas 22q11.2 DS VOs showed only 149.

This breakdown in communication led to a misalignment between endothelial tubes and their supporting mural cells. To compensate for the lack of direct structural support, the diseased organoids upregulated extracellular matrix (ECM) organization. Signaling strength for ECM-receptor interactions (involving collagen and fibronectin) skyrocketed from ~7.89 in controls to ~39.03 in the 22q11.2 DS group, suggesting an attempt to stabilize a failing system through chemical "glue" rather than cellular architecture.

Discussion and Future Directions

This study demonstrates that the vasculopathy in 22q11.2 DS is not merely a lack of growth, but a failure of coordination. The increased sprouting observed in diseased organoids represents an unstable, "leaky" developmental state caused by the inability of endothelial cells to effectively signal to mural cells.

While there was some variability between patient cell lines—reflecting the clinical heterogeneity of the syndrome—the VO platform successfully recapitulated key clinical presentations. This organoid-on-a-chip approach offers a promising path for high-throughput drug screening. Future research may focus on small molecules that can restore muted signaling pathways (such as VEGF or CD99) to "rescue" the vascular phenotype and improve outcomes for patients with 22q11.2 Deletion Syndrome.

Summary updated

Abstract

Abstract DiGeorge Syndrome, or 22q11.2 deletion syndrome (22q11.2 DS), is a genetic disorder caused by microdeletions in chromosome 22, impairing the function of endothelial cells (EC) and/or mural cells and leading to deficits in blood vessel development such as abnormal aortic arch morphology, tortuous retinal vessels, and tetralogy of Fallot. The mechanism by which dysfunctional endothelial cells and pericytes contribute to the vasculopathy, however, remains unknown. In this study, we used human blood vessel organoids (VOs) generated from iPSC of 22q11.2 DS patients to model the vascular malformations and genetic dysfunctions. We combined high-resolution lightsheet imaging and single-cell transcriptome analysis to link the genetic profile and vascular phenotype at the single-cell level. We developed a comprehensive analytical methodology by integrating deep learning-mediated blood vessel segmentation, network graph construction, and tessellation analysis for automated morphology characterization. We report that 22q11.2DS VOs demonstrate a smaller size with increased angiogenesis/sprouting, suggesting a less stable vascular network. Overall, clinical presentations of smaller vascular diameter, less connected vasculature, and increased branch points were recapitulated in 22q11.2DS VOs. Single-cell transcriptome profiling showed heterogeneity in both 22q11.2DS and control VOs, but the former demonstrated alterations in endothelial characteristics that are organ-specific and suggest a perturbation in the vascular developmental process. Intercellular communication analysis indicated that the vascular dysfunctions in 22q11.2 deletion were due to a lower cell-cell contact and upregulated extracellular matrix organization involving collagen and fibronectin. Voronoi diagram-based tessellation analysis also indicated that the colocalization of endothelial tubes and mural cells was different between control and 22q11.2 VOs, indicating that alterations in EC and mural interactions might contribute to the deficits in vascular network formation. This study illustrates the utility of VO in revealing the pathogenesis of 22q11.2DS vasculopathy.
BibTeX
@misc{he2021mapping,
  author = {Siyu He and Cong Xu and Yeh‐Hsing Lao and Shradha Chauhan and Yang Xiao and Moshe J. Willner and Yinuo Jin and Shannon McElroy and Sneha Rao and Joseph A. Gogos and Raju Tomer and Elham Azizi and Bin Xu and Kam W. Leong},
  title = {{Mapping morphological malformation to genetic dysfunction in blood vessel organoids with 22q11.2 Deletion Syndrome}},
  year = {2021},
  doi = {10.1101/2021.11.17.468969},
  howpublished = {bioRxiv},
}
Figure